{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T02:08:19Z","timestamp":1778810899948,"version":"3.51.4"},"reference-count":68,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2011,1,18]],"date-time":"2011-01-18T00:00:00Z","timestamp":1295308800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/2.0"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["BMC Pregnancy Childbirth"],"published-print":{"date-parts":[[2011,12]]},"DOI":"10.1186\/1471-2393-11-5","type":"journal-article","created":{"date-parts":[[2011,2,8]],"date-time":"2011-02-08T07:15:21Z","timestamp":1297149321000},"source":"Crossref","is-referenced-by-count":36,"title":["A new fetal RHD genotyping test: Costs and benefits of mass testing to target antenatal anti-D prophylaxis in England and Wales"],"prefix":"10.1186","volume":"11","author":[{"given":"Ala","family":"Szczepura","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Leeza","family":"Osipenko","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Karoline","family":"Freeman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2011,1,18]]},"reference":[{"key":"363_CR1","volume-title":"Technology appraisals TA41","author":"NICE","year":"2002","unstructured":"NICE: The clinical effectiveness and cost effectiveness of routine anti-D prophylaxis for RhD-negative women in pregnancy. Technology appraisals TA41. 2002"},{"issue":"7122","key":"363_CR2","doi-asserted-by":"publisher","first-page":"1588","DOI":"10.1136\/bmj.315.7122.1588","volume":"315","author":"S Mayne","year":"1997","unstructured":"Mayne S, Parker JH, Harden TA, Dodds SD, Beale JA: Rate of RhD sensitisation before and after implementation of a community based antenatal prophylaxis programme. BMJ. 1997, 315 (7122): 1588-","journal-title":"BMJ"},{"issue":"12","key":"363_CR3","doi-asserted-by":"publisher","first-page":"1661","DOI":"10.1111\/j.0041-1132.2003.00632.x","volume":"43","author":"J Bowman","year":"2003","unstructured":"Bowman J: Thirty-five years of Rh prophylaxis. Transfusion. 2003, 43 (12): 1661-1666. 10.1111\/j.0041-1132.2003.00632.x.","journal-title":"Transfusion"},{"issue":"5","key":"363_CR4","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1111\/j.1365-3148.2007.00777.x","volume":"17","author":"B Chaffe","year":"2007","unstructured":"Chaffe B, Ford J, Bills V: Routine antenatal anti-D prophylaxis and patient compliance with the two-dose regimen. Transfus Med. 2007, 17 (5): 399-403. 10.1111\/j.1365-3148.2007.00777.x.","journal-title":"Transfus Med"},{"issue":"7","key":"363_CR5","doi-asserted-by":"publisher","first-page":"839","DOI":"10.1111\/j.1471-0528.2006.00988.x","volume":"113","author":"IZ MacKenzie","year":"2006","unstructured":"MacKenzie IZ, Findlay J, Thompson K, Roseman F: Compliance with routine antenatal rhesus D prophylaxis and the impact on sensitisations: observations over 14 years. BJOG. 2006, 113 (7): 839-843. 10.1111\/j.1471-0528.2006.00988.x.","journal-title":"BJOG"},{"key":"363_CR6","volume-title":"Technology appraisals TA156","author":"NICE","year":"2008","unstructured":"NICE: Pregnancy - routine anti-D prophylaxis for rhesus negative women (review of TA41). Technology appraisals TA156. 2008"},{"issue":"4","key":"363_CR7","doi-asserted-by":"publisher","first-page":"768","DOI":"10.1086\/301800","volume":"62","author":"YM Lo","year":"1998","unstructured":"Lo YM, Tein MS, Lau TK, Haines CJ, Leung TN, Poon PM, Wainscoat JS, Johnson PJ, Chang AM, Hjelm NM: Quantitative analysis of fetal DNA in maternal plasma and serum: implications for noninvasive prenatal diagnosis. Am J Hum Genet. 1998, 62 (4): 768-775. 10.1086\/301800.","journal-title":"Am J Hum Genet"},{"issue":"4","key":"363_CR8","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1159\/000085085","volume":"20","author":"I Hromadnikova","year":"2005","unstructured":"Hromadnikova I, Vechetova L, Vesela K, Benesova B, Doucha J, Kulovany E, Vlk R: Non-invasive fetal RHD exon 7 and exon 10 genotyping using real-time PCR testing of fetal DNA in maternal plasma. Fetal Diagn Ther. 2005, 20 (4): 275-280. 10.1159\/000085085.","journal-title":"Fetal Diagn Ther"},{"issue":"8","key":"363_CR9","doi-asserted-by":"publisher","first-page":"1079","DOI":"10.1046\/j.1537-2995.2002.00165.x","volume":"42","author":"KM Finning","year":"2002","unstructured":"Finning KM, Martin PG, Soothill PW, Avent ND: Prediction of fetal D status from maternal plasma: introduction of a new noninvasive fetal RHD genotyping service. Transfusion. 2002, 42 (8): 1079-1085. 10.1046\/j.1537-2995.2002.00165.x.","journal-title":"Transfusion"},{"issue":"2","key":"363_CR10","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1016\/j.siny.2007.12.012","volume":"13","author":"CE van der Schoot","year":"2008","unstructured":"van der Schoot CE, Hahn S, Chitty LS: Non-invasive prenatal diagnosis and determination of fetal Rh status. Semin Fetal Neonatal Med. 2008, 13 (2): 63-68. 10.1016\/j.siny.2007.12.012.","journal-title":"Semin Fetal Neonatal Med"},{"issue":"1","key":"363_CR11","doi-asserted-by":"publisher","first-page":"23","DOI":"10.2165\/00066982-200408010-00004","volume":"8","author":"C Rouillac-Le Sciellour","year":"2004","unstructured":"Rouillac-Le Sciellour C, Puillandre P, Gillot R, Baulard C, Metral S, Le Van Kim C, Cartron JP, Colin Y, Brossard Y: Large-scale pre-diagnosis study of fetal RHD genotyping by PCR on plasma DNA from RhD-negative pregnant women. Mol Diagn. 2004, 8 (1): 23-31. 10.2165\/00066982-200408010-00004.","journal-title":"Mol Diagn"},{"key":"363_CR12","volume-title":"Final Report Health Care Efficiency Research Programme","author":"C van der Schoot","year":"2005","unstructured":"van der Schoot C: Prenatal fetal RhD blood group typing to enhance efficiency of antenatal anti-D immunoprophylaxis in RhD negative pregnant women. Final Report Health Care Efficiency Research Programme. 2005"},{"issue":"4","key":"363_CR13","doi-asserted-by":"publisher","first-page":"1163","DOI":"10.1016\/j.ajog.2006.07.033","volume":"195","author":"O Geifman-Holtzman","year":"2006","unstructured":"Geifman-Holtzman O, Grotegut CA, Gaughan JP: Diagnostic accuracy of noninvasive fetal Rh genotyping from maternal blood-a meta-analysis. Am J Obstet Gynecol. 2006, 195 (4): 1163-1173. 10.1016\/j.ajog.2006.07.033.","journal-title":"Am J Obstet Gynecol"},{"issue":"2","key":"363_CR14","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1111\/j.1537-2995.2007.01533.x","volume":"48","author":"JM Minon","year":"2008","unstructured":"Minon JM, Gerard C, Senterre JM, Schaaps JP, Foidart JM: Routine fetal RHD genotyping with maternal plasma: a four-year experience in Belgium. Transfusion. 2008, 48 (2): 373-381.","journal-title":"Transfusion"},{"issue":"2","key":"363_CR15","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1016\/j.ejogrb.2008.10.010","volume":"142","author":"K Freeman","year":"2009","unstructured":"Freeman K, Szczepura A, Osipenko L: Non-invasive fetal RHD genotyping tests: a systematic review of the quality of reporting of diagnostic accuracy in published studies. Eur J Obstet Gynecol Reprod Biol. 2009, 142 (2): 91-98.","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"issue":"7648","key":"363_CR16","doi-asserted-by":"publisher","first-page":"816","DOI":"10.1136\/bmj.39518.463206.25","volume":"336","author":"K Finning","year":"2008","unstructured":"Finning K, Martin P, Summers J, Massey E, Poole G, Daniels G: Effect of high throughput RHD typing of fetal DNA in maternal plasma on use of anti-RhD immunoglobulin in RhD negative pregnant women: prospective feasibility study. BMJ. 2008, 336 (7648): 816-818. 10.1136\/bmj.39518.463206.25.","journal-title":"BMJ"},{"issue":"10","key":"363_CR17","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3310\/hta7100","volume":"7","author":"GM Grimshaw","year":"2003","unstructured":"Grimshaw GM, Szczepura A, Hulten M, MacDonald F, Nevin NC, Sutton F, Dhanjal S: Evaluation of molecular tests for prenatal diagnosis of chromosome abnormalities. Health Technol Assess. 2003, 7 (10): 1-146.","journal-title":"Health Technol Assess"},{"issue":"1-2","key":"363_CR18","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/j.tracli.2006.02.021","volume":"13","author":"CE van der Schoot","year":"2006","unstructured":"van der Schoot CE, Soussan AA, Koelewijn J, Bonsel G, Paget-Christiaens LG, de Haas M: Non-invasive antenatal RHD typing. Transfus Clin Biol. 2006, 13 (1-2): 53-57. 10.1016\/j.tracli.2006.02.021.","journal-title":"Transfus Clin Biol"},{"issue":"10","key":"363_CR19","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3310\/hta13100","volume":"13","author":"H Pilgrim","year":"2009","unstructured":"Pilgrim H, Lloyd-Jones M, Rees A: Routine antenatal anti-D prophylaxis for RhD-negative women: a systematic review and economic evaluation. Health Technol Assess. 2009, 13 (10): 1-103. iii, ix-xi","journal-title":"Health Technol Assess"},{"key":"363_CR20","volume-title":"SAFE NoE","author":"A Szczepura OL","year":"2007","unstructured":"Szczepura OL A, Freeman K: Non-Invasive Prenatal Diagnosis (NIPD): Fetal RHD Genotype: Early-HTA Report. SAFE NoE. 2007"},{"key":"363_CR21","unstructured":"UK National Statistics. [ http:\/\/www.statistics.gov.uk\/ ]"},{"key":"363_CR22","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1196\/annals.1368.011","volume":"1075","author":"G Daniels","year":"2006","unstructured":"Daniels G, Finning K, Martin P, Summers J: Fetal blood group genotyping: present and future. Ann N Y Acad Sci. 2006, 1075: 88-95. 10.1196\/annals.1368.011.","journal-title":"Ann N Y Acad Sci"},{"issue":"Suppl 18","key":"363_CR23","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1111\/j.1471-0528.1998.tb10285.x","volume":"105","author":"M Contreras","year":"1998","unstructured":"Contreras M: The prevention of Rh haemolytic disease of the fetus and newborn--general background. Br J Obstet Gynaecol. 1998, 105 (Suppl 18): 7-10.","journal-title":"Br J Obstet Gynaecol"},{"key":"363_CR24","volume-title":"Workpackage 6, SAFE Network of Excellence","author":"K Freeman","year":"2006","unstructured":"Freeman K, Osipenko L, Clay D, Hyde J, Szczepura A: A Review of Evidence on Non-invasive Prenatal Diagnosis (NIPD): Tests for Fetal RHD Genotype. Workpackage 6, SAFE Network of Excellence. 2006, Warwick Medical School, UK"},{"issue":"9","key":"363_CR25","doi-asserted-by":"publisher","first-page":"824","DOI":"10.1002\/pd.1783","volume":"27","author":"TJ Legler","year":"2007","unstructured":"Legler TJ, Liu Z, Mavrou A, Finning K, Hromadnikova I, Galbiati S, Meaney C, Hulten MA, Crea F, Olsson ML, et al: Workshop report on the extraction of foetal DNA from maternal plasma. Prenat Diagn. 2007, 27 (9): 824-829. 10.1002\/pd.1783.","journal-title":"Prenat Diagn"},{"key":"363_CR26","unstructured":"The SiriusWeb Staff Costs Calculator. [ http:\/\/www.siriusweb.leeds.ac.uk ]"},{"key":"363_CR27","unstructured":"Hematos System Description. [ http:\/\/www.savant.co.uk\/product\/hematos ]"},{"issue":"11","key":"363_CR28","doi-asserted-by":"publisher","first-page":"2292","DOI":"10.1111\/j.1537-2995.2008.01843.x","volume":"48","author":"SP Muller","year":"2008","unstructured":"Muller SP, Bartels I, Stein W, Emons G, Gutensohn K, Kohler M, Legler TJ: The determination of the fetal D status from maternal plasma for decision making on Rh prophylaxis is feasible. Transfusion. 2008, 48 (11): 2292-2301. 10.1111\/j.1537-2995.2008.01843.x.","journal-title":"Transfusion"},{"key":"363_CR29","unstructured":"NHS Reference Costs. [ http:\/\/www.dh.gov.uk\/en\/Publicationsandstatistics\/Publications\/PublicationsPolicyAndGuidance\/DH_082571 ]"},{"key":"363_CR30","unstructured":"Free DNA Fetal Kit\u00ae RhD. Kit de g\u00e9notypage foetal RhD \u00e0 partir d'ADN foetal libre du sang maternel. [ http:\/\/www.biotechjboy.com\/biologie_moleculaire\/biologie_moleculaire.htm ]"},{"issue":"4","key":"363_CR31","doi-asserted-by":"publisher","first-page":"iii","DOI":"10.3310\/hta7040","volume":"7","author":"J Chilcott","year":"2003","unstructured":"Chilcott J, Lloyd Jones M, Wight J, Forman K, Wray J, Beverley C, Tappenden P: A review of the clinical effectiveness and cost-effectiveness of routine anti-D prophylaxis for pregnant women who are rhesus-negative. Health Technol Assess. 2003, 7 (4): iii-62.","journal-title":"Health Technol Assess"},{"issue":"Suppl 18","key":"363_CR32","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1111\/j.1471-0528.1998.tb10286.x","volume":"105","author":"SJ Urbaniak","year":"1998","unstructured":"Urbaniak SJ: The scientific basis of antenatal prophylaxis. Br J Obstet Gynaecol. 1998, 105 (Suppl 18): 11-18.","journal-title":"Br J Obstet Gynaecol"},{"issue":"8344","key":"363_CR33","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1016\/S0140-6736(83)90232-5","volume":"2","author":"LA Tovey","year":"1983","unstructured":"Tovey LA, Townley A, Stevenson BJ, Taverner J: The Yorkshire antenatal anti-D immunoglobulin trial in primigravidae. Lancet. 1983, 2 (8344): 244-246. 10.1016\/S0140-6736(83)90232-5.","journal-title":"Lancet"},{"issue":"10","key":"363_CR34","first-page":"11","volume":"3","author":"S Wickham","year":"2000","unstructured":"Wickham S: Midwives and anti-D. Enabling choice. Pract Midwife. 2000, 3 (10): 11-12.","journal-title":"Pract Midwife"},{"issue":"4","key":"363_CR35","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1590\/S0104-42302006000400022","volume":"52","author":"IN Machado","year":"2006","unstructured":"Machado IN, Castilho L, Pellegrino J, Barini R: Fetal rhd genotyping from maternal plasma in a population with a highly diverse ethnic background. Rev Assoc Med Bras. 2006, 52 (4): 232-235. 10.1590\/S0104-42302006000400022.","journal-title":"Rev Assoc Med Bras"},{"issue":"953","key":"363_CR36","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1136\/pgmj.2004.026237","volume":"81","author":"A Szczepura","year":"2005","unstructured":"Szczepura A: Access to health care for ethnic minority populations. Postgrad Med J. 2005, 81 (953): 141-147. 10.1136\/pgmj.2004.026237.","journal-title":"Postgrad Med J"},{"issue":"11","key":"363_CR37","doi-asserted-by":"publisher","first-page":"1663","DOI":"10.1111\/j.0041-1132.2004.04237.x","volume":"44","author":"CM Westhoff","year":"2004","unstructured":"Westhoff CM: The Rh blood group system in review: a new face for the next decade. Transfusion. 2004, 44 (11): 1663-1673. 10.1111\/j.0041-1132.2004.04237.x.","journal-title":"Transfusion"},{"issue":"3","key":"363_CR38","doi-asserted-by":"publisher","first-page":"438","DOI":"10.1309\/AJCPSXN9HQ4DELJE","volume":"134","author":"D Wang","year":"2010","unstructured":"Wang D, Lane C, Quillen K: Prevalence of RhD variants, confirmed by molecular genotyping, in a multiethnic prenatal population. Am J Clin Pathol. 2010, 134 (3): 438-442. 10.1309\/AJCPSXN9HQ4DELJE.","journal-title":"Am J Clin Pathol"},{"key":"363_CR39","first-page":"26","volume":"21","author":"N Ali","year":"2005","unstructured":"Ali N, Anwar M, Bhatti F, Nadeem M, Nadeem A, Ali M: Frequency of ABO and Rh blood groups in major ethnic groups and casts of Pakistan. Pakistan J Med Sci. 2005, 21: 26-29.","journal-title":"Pakistan J Med Sci"},{"issue":"6","key":"363_CR40","doi-asserted-by":"publisher","first-page":"633","DOI":"10.1016\/0002-9378(84)90248-5","volume":"149","author":"MM Adams","year":"1984","unstructured":"Adams MM, Marks JS, Koplan JP: Cost implications of routine antenatal administration of Rh immune globulin. Am J Obstet Gynecol. 1984, 149 (6): 633-638.","journal-title":"Am J Obstet Gynecol"},{"key":"363_CR41","unstructured":"Equality Act 2010. [ http:\/\/www.equalities.gov.uk\/equality_act_2010.aspx ]"},{"issue":"9","key":"363_CR42","doi-asserted-by":"publisher","first-page":"903","DOI":"10.1111\/j.1471-0528.2004.00226.x","volume":"111","author":"J Chilcott","year":"2004","unstructured":"Chilcott J, Tappenden P, Lloyd Jones M, Wight J, Forman K, Wray J, Beverley C: The economics of routine antenatal anti-D prophylaxis for pregnant women who are rhesus negative. BJOG. 2004, 111 (9): 903-907. 10.1111\/j.1471-0528.2004.00226.x.","journal-title":"BJOG"},{"key":"363_CR43","volume-title":"University of Amsterdam","author":"J Koelewijn","year":"2009","unstructured":"Koelewijn J: Detection and prevention of pregnancy immunisation. The OPZI-study. Doctoral Thesis. University of Amsterdam. 2009"},{"issue":"2","key":"363_CR44","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1111\/j.1423-0410.2007.00945.x","volume":"93","author":"BM Kumpel","year":"2007","unstructured":"Kumpel BM: Efficacy of RhD monoclonal antibodies in clinical trials as replacement therapy for prophylactic anti-D immunoglobulin: more questions than answers. Vox Sang. 2007, 93 (2): 99-111. 10.1111\/j.1423-0410.2007.00945.x.","journal-title":"Vox Sang"},{"issue":"11","key":"363_CR45","doi-asserted-by":"publisher","first-page":"1040","DOI":"10.1002\/pd.1248","volume":"25","author":"FB Clausen","year":"2005","unstructured":"Clausen FB, Krog GR, Rieneck K, Nielsen LK, Lundquist R, Finning K, Dickmeiss E, Hedegaard M, Dziegiel MH: Reliable test for prenatal prediction of fetal RhD type using maternal plasma from RhD negative women. Prenat Diagn. 2005, 25 (11): 1040-1044. 10.1002\/pd.1248.","journal-title":"Prenat Diagn"},{"issue":"4","key":"363_CR46","doi-asserted-by":"publisher","first-page":"678","DOI":"10.1373\/49.4.678","volume":"49","author":"LY Chan","year":"2003","unstructured":"Chan LY, Leung TN, Chan KC, Tai HL, Lau TK, Wong EM, Lo YM: Serial analysis of fetal DNA concentrations in maternal plasma in late pregnancy. Clin Chem. 2003, 49 (4): 678-680. 10.1373\/49.4.678.","journal-title":"Clin Chem"},{"issue":"1","key":"363_CR47","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1046\/j.1365-2141.2002.03780.x","volume":"119","author":"JM Costa","year":"2002","unstructured":"Costa JM, Giovangrandi Y, Ernault P, Lohmann L, Nataf V, El Halali N, Gautier E: Fetal RHD genotyping in maternal serum during the first trimester of pregnancy. Br J Haematol. 2002, 119 (1): 255-260. 10.1046\/j.1365-2141.2002.03780.x.","journal-title":"Br J Haematol"},{"key":"363_CR48","unstructured":"SensiGene Fetal RHD Genotyping. [ http:\/\/www.scmmlab.com\/Home\/Health-Care-Professionals\/Fetal-RHD-Genotyping ]"},{"issue":"3","key":"363_CR49","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1016\/0168-8278(91)90076-N","volume":"13","author":"S Dittmann","year":"1991","unstructured":"Dittmann S, Roggendorf M, Durkop J, Wiese M, Lorbeer B, Deinhardt F: Long-term persistence of hepatitis C virus antibodies in a single source outbreak. J Hepatol. 1991, 13 (3): 323-327. 10.1016\/0168-8278(91)90076-N.","journal-title":"J Hepatol"},{"issue":"8930","key":"363_CR50","doi-asserted-by":"publisher","first-page":"1166","DOI":"10.1016\/S0140-6736(94)90679-3","volume":"344","author":"JP Power","year":"1994","unstructured":"Power JP, Lawlor E, Davidson F, Yap PL, Kenny-Walsh E, Whelton MJ, Walsh TJ: Hepatitis C viraemia in recipients of Irish intravenous anti-D immunoglobulin. Lancet. 1994, 344 (8930): 1166-1167. 10.1016\/S0140-6736(94)90679-3.","journal-title":"Lancet"},{"issue":"2","key":"363_CR51","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1016\/j.tmrv.2006.11.001","volume":"21","author":"T Burnouf","year":"2007","unstructured":"Burnouf T: Modern plasma fractionation. Transfus Med Rev. 2007, 21 (2): 101-117. 10.1016\/j.tmrv.2006.11.001.","journal-title":"Transfus Med Rev"},{"issue":"1","key":"363_CR52","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.biologicals.2003.08.004","volume":"32","author":"L Gregori","year":"2004","unstructured":"Gregori L, Maring JA, MacAuley C, Dunston B, Rentsch M, Kempf C, Rohwer RG: Partitioning of TSE infectivity during ethanol fractionation of human plasma. Biologicals. 2004, 32 (1): 1-10. 10.1016\/j.biologicals.2003.08.004.","journal-title":"Biologicals"},{"key":"363_CR53","volume-title":"World Federation of Haemophilia","author":"A Farrugia","year":"2001","unstructured":"Farrugia A: vCJD donor deferral measures. Montreal. World Federation of Haemophilia. 2001"},{"key":"363_CR54","unstructured":"Revised preventive measures to reduce the possible risk of transmission of Creutzfeldt-Jakob disease (CJD) and variant Cruetzfeldt-Jakob disease (vCJD) by blood and blood products. [ http:\/\/www.fda.gov\/ohrms\/dockets\/ac\/01\/briefing\/3796b1_03.pdf ]"},{"key":"363_CR55","unstructured":"Wickham S: Rhogam: evidence from midwives. Midwifery Today Int Midwife. 2000, 44-45. 53"},{"key":"363_CR56","volume-title":"ZonMw","author":"G Bonsel","year":"2005","unstructured":"Bonsel G, et al: Final Report Health Care Efficiency Research Programme. ZonMw. 2005"},{"key":"363_CR57","volume-title":"Workpackage 6, SAFE Network of Excellence","author":"A Szczepura","year":"2007","unstructured":"Szczepura A, Osipenko L, Freeman K: Emerging technologies in the management of RhD negative pregnant women. Workpackage 6, SAFE Network of Excellence. 2007, Warwick Medical School, UK"},{"issue":"1","key":"363_CR58","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1111\/j.1365-2249.2008.03735.x","volume":"154","author":"BM Kumpel","year":"2008","unstructured":"Kumpel BM: Lessons learnt from many years of experience using anti-D in humans for prevention of RhD immunization and haemolytic disease of the fetus and newborn. Clin Exp Immunol. 2008, 154 (1): 1-5. 10.1111\/j.1365-2249.2008.03735.x.","journal-title":"Clin Exp Immunol"},{"key":"363_CR59","unstructured":"Symphogen. Sym001 (anti-RhD). [ http:\/\/www.symphogen.com\/web\/guest\/sym001 ]"},{"issue":"6","key":"363_CR60","doi-asserted-by":"publisher","first-page":"677","DOI":"10.1097\/MOH.0b013e3282ef1838","volume":"14","author":"J Storry","year":"2007","unstructured":"Storry J: New technologies to replace current blood typing reagents. Current Opinion in Hemotology. 2007, 14 (6): 677-681. 10.1097\/MOH.0b013e3282ef1838.","journal-title":"Current Opinion in Hemotology"},{"issue":"6","key":"363_CR61","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1080\/01443610701469941","volume":"27","author":"TG Hirose","year":"2007","unstructured":"Hirose TG, Mays DA: The safety of RhIG in the prevention of haemolytic disease of the newborn. J Obstet Gynaecol. 2007, 27 (6): 545-557. 10.1080\/01443610701469941.","journal-title":"J Obstet Gynaecol"},{"key":"363_CR62","unstructured":"Prenatal Diagnostics. [ http:\/\/www.sequenom.com\/Home\/Products---Services\/Diagnostics\/Prenatal-Diagnostics ]"},{"key":"363_CR63","unstructured":"Lab Prepares Launch of Trisomy 21 Diagnostic Test. [ http:\/\/www.labmedica.com\/lab_technology\/articles\/294730804\/lab_prepares_launch_of_trisomy_21_diagnostic_test.html ]"},{"issue":"9560","key":"363_CR64","doi-asserted-by":"publisher","first-page":"474","DOI":"10.1016\/S0140-6736(07)60115-9","volume":"369","author":"R Dhallan","year":"2007","unstructured":"Dhallan R, Guo X, Emche S, Damewood M, Bayliss P, Cronin M, Barry J, Betz J, Franz K, Gold K, et al: A non-invasive test for prenatal diagnosis based on fetal DNA present in maternal blood: a preliminary study. Lancet. 2007, 369 (9560): 474-481. 10.1016\/S0140-6736(07)60115-9.","journal-title":"Lancet"},{"issue":"32","key":"363_CR65","doi-asserted-by":"publisher","first-page":"13116","DOI":"10.1073\/pnas.0705765104","volume":"104","author":"YM Lo","year":"2007","unstructured":"Lo YM, Lun FM, Chan KC, Tsui NB, Chong KC, Lau TK, Leung TY, Zee BC, Cantor CR, Chiu RW: Digital PCR for the molecular detection of fetal chromosomal aneuploidy. Proc Natl Acad Sci USA. 2007, 104 (32): 13116-13121. 10.1073\/pnas.0705765104.","journal-title":"Proc Natl Acad Sci USA"},{"issue":"1","key":"363_CR66","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1002\/ajmg.c.30115","volume":"145C","author":"JL Maron","year":"2007","unstructured":"Maron JL, Bianchi DW: Prenatal diagnosis using cell-free nucleic acids in maternal body fluids: a decade of progress. Am J Med Genet C Semin Med Genet. 2007, 145C (1): 5-17. 10.1002\/ajmg.c.30115.","journal-title":"Am J Med Genet C Semin Med Genet"},{"issue":"1","key":"363_CR67","first-page":"8","volume":"8","author":"GM Liumbruno","year":"2010","unstructured":"Liumbruno GM, D'Alessandro A, Rea F, Piccinini V, Catalano L, Calizzani G, Pupella S, Grazzini G: The role of antenatal immunoprophylaxis in the prevention of maternal-foetal anti-Rh(D) alloimmunisation. Blood Transfus. 2010, 8 (1): 8-16.","journal-title":"Blood Transfus"},{"issue":"1","key":"363_CR68","first-page":"7","volume":"5","author":"C Velati","year":"2007","unstructured":"Velati C: A survey of the current use of anti-D immunoprophylaxis and the incidence of haemolytic disease of the newborn in Italy. Blood Transfus. 2007, 5 (1): 7-14.","journal-title":"Blood Transfus"}],"container-title":["BMC Pregnancy and Childbirth"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1186\/1471-2393-11-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2393-11-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2393-11-5","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2393-11-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,4,3]],"date-time":"2024-04-03T23:22:38Z","timestamp":1712186558000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcpregnancychildbirth.biomedcentral.com\/articles\/10.1186\/1471-2393-11-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,1,18]]},"references-count":68,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2011,12]]}},"alternative-id":["363"],"URL":"https:\/\/doi.org\/10.1186\/1471-2393-11-5","relation":{},"ISSN":["1471-2393"],"issn-type":[{"value":"1471-2393","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,1,18]]},"article-number":"5"}}